TEVA Market Cap History
tm2031881d1_ex99-1img006.jpg
Teva beats analysts with $1.1b Q3 profit - Globes
J&J prostate cancer drug scores FDA nod; Buffett's investment lifts Teva stocks | S&P Global Market Intelligence
Institutions Have Been Holding Back, but Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Beginning to Stabilize
Big stock buyback: Allergen plans $10 b share repurchase - The Financial Express
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement | Business Wire
Hertz Plans $2B Share Repurchase Program
Teva board OKs $3 billion stock repurchase | Modern Healthcare
No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn't Doomed | Nasdaq
Stocks - Fitbit, Teva, DowDuPont Jump in Pre-market; Wayfair, Spotify Plunge By Investing.com
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results | AbbVie News Center
TEVA - Analyst Reports
PPT - Health Care: Stock Presentation PowerPoint Presentation, free download - ID:3413855
Teva Pharmaceutical Industries Insider Buying and Selling (NYSE:TEVA)
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
3 Large-Cap Stocks Worth Buying in 2017 | The Motley Fool
TXMD Awaits Big Day Next Week, TEVA Faces FDA In Sep., ESPR On Watch
Teva approves $3 billion share buyback - Business - Haaretz.com
Hale & Tempest Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest - ppt download
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry
Form 10-K
Teva lining up alone in EM bonds
Why Teva Stock Could Be the Next General Electric Stock | InvestorPlace
